Atopic Dermatitis | Coherus | CHS-0214-05

Pharmaceutical Company/Sponsor:

Coherus

Code:

CHS-0214-05

Title:

An open-label safety extension study (OLSES) evaluating the long-term safety and durability of response of CHS-0214 (CHS-0214-05)

Type:

Phase:

Condition/Disease:

Atopic Dermatitis

Intervention(s)/Treatment(s):

Status:

Completed

Link for Additional Information: